Mahamaya Lifesciences Limited (BOM:544611)
186.00
-2.00 (-1.06%)
At close: Aug 14, 2026
60.34% (1Y)
| Market Cap | 4.35B |
| Revenue (ttm) | 3.29B +24.5% |
| Net Income | 165.23M +29.0% |
| EPS | 8.33 +10.4% |
| Shares Out | 23.41M |
| PE Ratio | 22.33 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,800 |
| Open | 193.25 |
| Previous Close | 188.00 |
| Day's Range | 186.00 - 193.25 |
| 52-Week Range | 111.00 - 205.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 1, 2026 |